Adial Pharmaceuticals, Inc
About
2.40USD-0.13 -5.14%
Closed • Updated at 04:46 GMT+00:00Market Cap$5.14M
Volume42.8K
Beta2.58
RSI67.41
Adial Pharmaceuticals, Inc — investor relations, events, news, and company updates on 6ix.
Latest News
May 11 2026
Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update
Apr 29 2026
Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045
Apr 27 2026
Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program
Apr 22 2026
Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial
Mar 24 2026
Adial Pharmaceuticals Commends Congress on Introduction of Bipartisan Legislation Expanding Access to Emerging AUD Therapies for Veterans
Recent Videos
POTENTIAL BREAKOUT | ADIL STOCK ANALYSIS | ADIAL PHARMACEUTICALS STOCK
May 23, 2026
A Breakthrough for Alcohol Use Disorder? New Treatment Offers Hope for Patients & Families Big Biz
Apr 30, 2026
Cary Claiborne, CEO of Adial Pharmaceuticals | The Big Biz Show
Apr 13, 2026
Revolutionary Breakthrough: A Precision Drug to Help People Drink Less Big Biz Show
Apr 08, 2026
Community Chat
Ask AI
Try asking